The Australian Government announced a COVID-19 Vaccine National rollout plan which commenced 21 February 2021. Delivery of the vaccine is in phases, beginning with aged care and disability care residents and staff.
The Australian Department of Home Affairs website has Vaccine and Coronavirus myth-busting information. If anyone is hesitant or unsure, speak with your doctor.
NDS has created "COVID Vaccine - Getting it done in disability", a video to assist providers in encouraging their staff and participants to get a COVID-19 Vaccine.
Disability support worker priority eligibility
Victorian disability support workers aged 40 years or younger can use this letter as proof of eligibility for their COVID Vaccination at any Victorian high volume vaccination site and hospital or GP clinics where they can provide both types of COVID vaccines.
People with disability priority eligibility
NDIS participants and other community members currently eligible for the vaccination program have priority access to vaccination hubs. This letter may be used as proof of eligibility.
Department of Health Webinar: Phase 1a COVID-19 disability vaccine rollout - 4 March 2021
While there is no work, health and safety (WHS) requirement that you must implement a policy around the COVID-19 vaccine, it is important for all employers to review and update their organisational WHS policies regarding infection control and COVID-19 in the workplace. For disability organisations intending to mandate or even strongly encourage COVID-19 vaccinations, it is advisable to develop a vaccination policy.
WorkPlacePLUS has developed Q and A based guidance to assist providers in determining whether vaccinations should be mandated within their organisations. We recommend members seek tailored advice before finalising their decision.
Our partnership with WorkPlacePLUS means NDS members can access discounted, tailored IR and HR advice.
NDS is continuing to advocate at a federal and state level for COVID-19 vaccinations to be mandated via Public Health Orders.
NDS's policy position on the vaccine was confirmed by the NDS Board on 11 February 2021.